Patent ID: 11883383
Assignee: VTV THERAPEUTICS LLC
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 2:
3. A crystalline form of a hydrobromide salt of [3-(4-{2-butyl-1-[4-(4-chlorophenoxy)phenyl]-1H-imidazol-4-yl}phenoxy)-propyl]-diethylamine, wherein the crystalline form is:
a) characterized by at least two of the following features (I-i)-(I-iv):
(I-i) an X-ray Powder Diffraction (XRPD) pattern having peaks at 2θ angles of 4.1°, 13.1°, and 16.4°±0.2°;
(I-i) a Differential Scanning calorimetry (DSC) profile as shown in FIG. 45;
(I-iii) a Thermogravimetric Analysis (TGA) profile as shown in FIG. 45; or
(I-iv) a 13C Solid-state Nuclear Magnetic Resonance (SSNMR) spectrum as shown in FIG. 67; or

b) characterized by at least two of the following features (I-i)-(I-iv):
(I-i) an XRPD pattern having peaks at 2θ angles of 9.3°, 20.9°, and 23.0°±0.2°;
(I-ii) a DSC profile as shown in FIG. 47;
(I-iii) a TGA profile as shown in FIG. 47; or
(I-iv) a 13C SSNMR spectrum as shown in FIG. 68.